Canadian pharmacists are gaining clinical authority at a pace not seen in decades. Ontario's minor ailments program continues to grow, British Columbia introduced a landmark change allowing pharmacists to order and interpret lab tests, and Saskatchewan is investing in advanced prescribing training for chronic disease management.
These developments reflect a broader recognition that pharmacists are underutilized clinical professionals. With physician shortages affecting millions of Canadians, expanding pharmacist scope of practice is both a practical solution and a long-overdue acknowledgment of pharmacist expertise.
Ontario's Minor Ailments Program Expands
Ontario launched its pharmacist prescribing program for minor ailments in January 2023, initially covering 13 conditions. The program allows pharmacists to assess patients and prescribe medications for common conditions without requiring a physician visit.
The list of eligible conditions has continued to grow, covering ailments such as urinary tract infections, pink eye, allergic rhinitis, skin rashes, acid reflux, cold sores, and menstrual cramps, among others. For patients who might otherwise wait hours in an emergency room or weeks for a family doctor appointment, this represents a significant improvement in access to care.
Ontario pharmacists can prescribe from a defined list of medications for each condition. The prescriptions are limited in duration and require appropriate documentation and follow-up. If a patient's condition does not improve or falls outside the pharmacist's scope, referral to a physician is required.
The program has been widely used. Millions of assessments have been completed since launch, reducing pressure on emergency departments and walk-in clinics.
British Columbia's Lab Test Authority
Effective August 30, 2024, British Columbia became one of the first provinces to allow pharmacists to order and interpret laboratory tests. This is a significant expansion beyond prescribing for minor ailments.
The ability to order lab tests allows pharmacists to make more informed clinical decisions. For example, a pharmacist managing a patient's cholesterol medication can now order a lipid panel to assess whether the current dose is effective. A pharmacist prescribing for a suspected urinary tract infection can order a urine culture to confirm the diagnosis.
This authority positions BC pharmacists closer to a collaborative care model where they function as active members of the healthcare team rather than simply dispensing medications prescribed by others. It also reduces the need for patients to book separate appointments with a physician solely to obtain routine lab work.
The College of Pharmacists of British Columbia has published guidelines outlining which tests pharmacists can order, the clinical circumstances under which ordering is appropriate, and the documentation requirements.
Saskatchewan Invests in Advanced Prescribing
Saskatchewan took a different approach by investing in training infrastructure. The province funded the Advanced Pharmacy Prescribing Training program at the University of Saskatchewan, with the first cohort beginning in January 2025.
The program prepares pharmacists to prescribe for chronic conditions including asthma, diabetes, COPD, obesity, and hypertension. These are conditions that require ongoing management, medication adjustments, and monitoring. Pharmacists who complete the training will be able to initiate, adjust, and discontinue medications for these conditions within a collaborative care framework.
This model acknowledges that expanded scope requires expanded education. Rather than simply granting authority and expecting pharmacists to figure it out, Saskatchewan is building a structured training pathway that ensures pharmacists have the clinical knowledge and skills to prescribe safely for complex conditions.
What This Means for Pharmacy Practice
More clinical, less transactional. These changes push pharmacy practice further from a dispensing-focused model toward a clinical care model. Pharmacists will spend more time assessing patients, making clinical decisions, and documenting outcomes.
Workflow adjustments. Pharmacies will need to adapt their physical spaces, staffing models, and technology to support clinical assessments. Private consultation areas, appointment scheduling systems, and clinical documentation tools will become standard.
Interprofessional communication. As pharmacists take on more prescribing responsibility, communication with physicians and other healthcare providers becomes critical. Shared electronic health records and standardized communication protocols will help ensure continuity of care.
Patient education. Many patients are not yet aware that their pharmacist can prescribe medications or order lab tests. Pharmacies that proactively communicate these services will see higher uptake and better patient outcomes.
A National Trend
The direction is clear. Across Canada, pharmacist scope of practice is expanding. The specifics vary by province, but the trajectory is consistent: pharmacists are being trusted with greater clinical responsibility, and the evidence supports this shift. Patients benefit from faster access to care, the healthcare system benefits from reduced strain on physicians and emergency departments, and pharmacists benefit from practicing at the top of their training.